home > news > detailed info

Manufacturing Consultancy up 150% as Life Sciences prepare for a digital future

Zenith Technologies

Zenith Technologies, a world leader in delivering manufacturing software solutions to the life sciences industry, has seen a 150% rise in demand for its consultancy arm services.

Zenith’s Consultancy team offers guidance and support to businesses with the implementation of new digital technologies and has seen an increasing appetite for digitised manufacturing and using data to improve GMP manufacturing over the past 12 months

The growth of the service in 2018 was driven by a need to aid customers in collecting, contextualising and finding insights in their stored data. These insights can then be used to make informed decisions on production processes and the supply chain.

Jaqueline Hora, Global Digital and Data Analytics Lead at Zenith Technologies said: “The life science industry has seen a remarkable trend towards innovation utilising data and technology effectively. Digital strategies as well as manufacturing execution systems (MES) and automation are in great demand as a result.

“For customers implementing these digital strategies, project decision support as well as process, technology and project execution knowledge, are essential to ensure success.

“Our Consultancy team supports customers that are considering new technology projects and assists in developing strategies, governance and standards to provide a framework for success.

“Whether it be justifying ROI, validating a customer’s strategy, process and methodology implementation expertise or help with technology selection, Zenith has been there to support its customer base.

“Zenith’s intimate understanding of manufacturing systems, extensive process knowledge and significant experience serving the life science sector has ensured that our customers have the insight needed to make the best decision.”

The increase is in part a direct result of the emergence of Industry 4.0 with data integrity, data analytics, the internet of things, and cloud strategies becoming a reality throughout the life science industry.

The team’s growth is projected to continue into 2019 as the life science industry increases its focus on digitisation and using data to improve GMP manufacturing practices.

In a recent survey of the industry, Zenith found nearly 60% of participants believe that Industry 4.0 will drive the most change in life science over the next 5 years, with 75% of those aiming to invest in people to take advantage of emerging technologies.
phone +353 (0) 21 4370 200
email Unit 4, Portgate Business Park, Raffeen, Monkstown, Co. Cork, T12 RP29, Ireland
Print this page
Send to a friend
News and Press Releases

Clinical Trial Supply West Coast Conference 2019

Philadelphia, USA – April 24, 2019. This year’s Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B


Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement